Ferritin 发表于 2025-3-25 04:02:12

Die Kosten- und Leistungsstellenrechnung,nce of understanding the biology and mechanisms of cellular interactions within the tumor microenvironment (TME). A majority of antibodies in development for treating cancer are directed against immune checkpoints (ICs). They are being evaluated in more than 3000 clinical trials as first or second l

Accede 发表于 2025-3-25 10:56:57

http://reply.papertrans.cn/16/1585/158464/158464_22.png

characteristic 发表于 2025-3-25 11:57:13

978-3-030-72601-0The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl

FAWN 发表于 2025-3-25 19:53:53

http://reply.papertrans.cn/16/1585/158464/158464_24.png

翻布寻找 发表于 2025-3-26 00:01:35

http://reply.papertrans.cn/16/1585/158464/158464_25.png

frenzy 发表于 2025-3-26 03:14:43

Book 2021by inhibition of negative immune regulation. Many of the antibodies that are now being brought to market target precisely these immune checkpoint modulators...The book addresses a broad readership, ranging from professionals and experts in the field to residents and medical students..

隐藏 发表于 2025-3-26 06:57:22

http://reply.papertrans.cn/16/1585/158464/158464_27.png

connoisseur 发表于 2025-3-26 10:10:15

http://reply.papertrans.cn/16/1585/158464/158464_28.png

史前 发表于 2025-3-26 16:09:18

http://reply.papertrans.cn/16/1585/158464/158464_29.png

草率女 发表于 2025-3-26 17:18:48

https://doi.org/10.1007/978-3-642-92196-4id tumors. They have opened a window for treating cancers such as malignant melanomas that were previously resistant to therapy. Tumors that are particularly amenable to treatment with IC inhibitors are characterized by a high mutation rate and a significant number of tumor-infiltrating lymphocytes
页: 1 2 [3] 4 5
查看完整版本: Titlebook: Antibodies for Treating Cancer; Basics, Development, Melvyn Little Book 2021 The Editor(s) (if applicable) and The Author(s), under exclusi